Anti-rods and rings autoantibodies can occur in the hepatitis c-naïve population

Abstract

Insights

The anti-Rods and Rings autoantibody, previously linked to hepatitis C treatment, is present in the general population. Most individuals with this autoantibody show no history of hepatitis C infection, suggesting alternative causes.

Area of Science:

  • Immunology
  • Epidemiology
  • Autoimmunity

Background:

  • The anti-Rods and Rings autoantibody is associated with hepatitis C treatment, particularly involving CTP and GTP synthetic pathway inhibitors.
  • Its presence may impact therapeutic response, necessitating further investigation into its origins.

Purpose of the Study:

  • To determine the epidemiology of the anti-Rods and Rings autoantibody in the general, non-clinical population.
  • To investigate the prevalence and demographic distribution of anti-RR autoantibodies.

Main Methods:

  • Cross-sectional study utilizing the National Health and Nutrition Examination Survey (NHANES) data.
  • Immunofluorescence assays were performed by NHANES laboratories.
  • Prevalence and distribution were calculated using sample weights, with a medication profile constructed for positive cases.

Main Results:

  • The study analyzed 4738 individuals over 12 years old.
  • Anti-Rods and Rings autoantibodies were detected in 39 individuals, representing 1.3 million people in the US.
  • Of those positive, 38 had no history of hepatitis C virus infection, and most reported polypharmacy.

Conclusions:

  • This study is the first to demonstrate the occurrence of anti-Rods and Rings autoantibodies in the general population without hepatitis C virus infection.
  • The findings suggest potential alternative etiologies for anti-RR autoantibodies beyond hepatitis C virus infection and its treatment.
  • Further research is needed to identify these alternative causes.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
86
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion...
25
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
28
Rh Blood Group01:19

Rh Blood Group

The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
4.3K
Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.0K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.4K